No insider purchase over the last 90 days. The latest, by 2018큐씨피13호사모투자, was filed 01 Apr 2026.
Seoul Pharma Co., Ltd: what insiders have been doing
This page follows insider dealings at Seoul Pharma Co., Ltd as filed with DART (FSS), a company from the Health Care sector. From 2 November 2025 to 2 November 2026, the disclosure feed for Seoul Pharma Co., Ltd logged 2 filings by 2 insiders.
The flow runs one way only: 2 insiders bought (2 purchases) and nobody sold on the market. No amount is published for 2 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 1 chief executive.
For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 2 filings here. Since 2022, the database holds 4 purchases and no sales by insiders of the company.
The clock since the last published purchase (1 April 2026) now reads 221 days.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -37.6%Entry ₩2,710 · Close 30 Oct 2026 ₩1,691
- -36.9%Entry ₩2,680 · Close 30 Oct 2026 ₩1,691
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 8,291 sharesKRXDART:20260331004950Canonical exit: 24 Jun 2026 (T+90)
- 8,291 sharesShareKRXDART:20260327001712Canonical exit: 24 Jun 2026 (T+90)
- 8,291 sharesKRXDART:20221130002033Canonical exit: 28 Feb 2023 (T+90)
- ShareKRXDART:20221130002035Canonical exit: 28 Feb 2023 (T+90)
4 of 4 declarations
About Seoul Pharma Co., Ltd
서울제약 is a company operating in the health and pharmaceutical sector, listed on the XKRX exchange. It focuses on the research, development, and production of medicines and pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
